Hilltimes
Menu
Get free News Updates Sign in
×
Tuesday, October 13, 2026
Canada’s Politics and Government News Source Since 1989
Subscribe Now

Policy

Bill C-39 dismantles Canada’s environmental policy ‘beyond anything we’ve ever seen,’ say climate groups  

While one Greenpeace campaigner says the legislation grants cabinet ‘unchecked discretion’ to circumvent environmental laws, for CSG Senator Clément Gignac, it’s ‘a very large positive step in the right direction’ for the economy.

news | BY ELEANOR WAND | September 27, 2026

‘Overcorrected’ international student cap a challenge for attracting talent, say post-secondary education reps

The federal government set a target of 155,000 new international student arrivals for 2026. However, according to Universities Canada, only 28,200 had arrived as of July 31, or about 18 per cent of the annual target.

news | BY JESSE CNOCKAERT | September 23, 2026

Canada’s universities can boost sovereignty by converting more research into impact

We have no shortage of talent or ideas, but we need greater entrepreneurial momentum and smoother pathways to convert more of them into products, processes, and jobs.

opinion | BY SUSAN TIGHE | September 23, 2026

Building a deep bench: Canada needs to leverage its research advantage

In addition to importing star talent, a successful talent strategy must also develop, retain, and support researchers already here and those just starting their careers.

opinion | BY DAVID ROBINSON | September 23, 2026

Why startups, SMEs, universities, and incubators must sit at the centre of Canada’s defence innovation strategy

Large firms remain important, but they must sit alongside a dense ecosystem of agile domestic companies that solve niche technical problems, and scale into trusted suppliers at home and abroad.

opinion | BY AARON JOHNSON | September 23, 2026
David McGuinty

Building capacity is a long-term project

Advanced expertise takes years to develop, and these capabilities cannot simply be created when a crisis emerges or a new priority appears.

opinion | BY ROBERT ASSELIN | September 23, 2026

Indigenous research is no longer a dirty word

Now, funding agencies need to create new structures, pathways, and policies that better reflect the interconnected nature of Indigenous Knowledges.

opinion | BY DAVID NEWHOUSE, JACQUELINE OTTMANN | September 23, 2026

Canada’s research advantage depends on what happens after discovery

We need to get better at turning ideas into impact without weakening the fundamental research that makes those discoveries possible in the first place.

opinion | BY GABRIEL MILLER | September 23, 2026

Scaling Canadian innovation for economic growth

The keys to building our next anchor companies lie in our university labs and incubators. It’s time to unlock Canada’s potential.

opinion | BY BENOIT-ANTOINE BACON, PETER ZANDSTRA | September 23, 2026

Canada and Europe: a natural partnership for a changing world

Closer ties with the EU can help us diversify our markets, strengthen our climate policies, and direct capital toward the technologies and infrastructure that will define the next economy.

opinion | BY CATHY ORLANDO | September 21, 2026

The 2026 federal budget must deliver stronger growth and sustainable finances: Drummond

Worsened access to the U.S. market limits Canadian firms’ ability to scale up and strengthen productivity, making it more difficult to compete in markets around the world.

opinion | BY DON DRUMMOND | September 21, 2026

Parliament to return with excitement, anxiety, and legislative agenda impacted by Trump

Economic transformation means layoffs and job losses. AI is another source of anxiety. What does that mean for us all in terms of a November budget?

opinion | BY TIM POWERS | September 18, 2026

An independent Senate will help navigate the challenges ahead

Parliament has a critical role to play, and the Senate is well-placed to represent Canada’s regions, diverse communities and stakeholders in the important discussions to come.

opinion | BY ISG SENATOR LUCIE MONCION | September 18, 2026

Senators and MPs alike must present a united Team Canada in face of escalating trade war

While parliamentarians may not always agree, we should avoid allowing partisan or procedural squabbles to overshadow the work at hand.

opinion | BY PSG SENATOR BRIAN FRANCIS | September 17, 2026

Order amidst complexity: the essential foundation for effective lawmaking

There is always pressure on the Senate to pass government legislation quickly, though that pressure has ratcheted up lately.

opinion | BY SENATOR FLORDELIZ (GIGI) OSLER | September 17, 2026

Canada’s biotech boom won’t matter if the growth happens somewhere else

Companies and investors need confidence that discoveries made in Canada can continue to be developed and commercialized here.

opinion | BY WENDY ZATYLNY | September 16, 2026
Marjorie Michel

Biotech success should not be measured in whether every Canadian company remains Canadian-owned

We should create and fund early-stage startups while allowing acquisitions—foreign or otherwise—to recycle capital, experienced executives, and technical expertise back into the ecosystem.

opinion | BY PIETER CULLIS, TERRI PETKAU | September 16, 2026

Canada losing ground in global life sciences race, needs quicker funding and harmonized clinical trials system, say sector experts

A promised $1-billion in the 2025 budget for the Venture and Growth Capital Catalyst Initiative—a program that includes a life sciences stream—has yet to begin flowing, according to Wendy Zatylny, president of BIOTECanada.

news | BY JESSE CNOCKAERT | September 16, 2026

Pharmacare for all: we cannot wait for the next health crisis

Our health-care system should not be a patchwork where some Canadians can access the medicine they need while others are left behind.

opinion | BY NDP MP GORD JOHNS | September 16, 2026

Bridging Canada’s life sciences gap: from world-class research to sovereign anchor companies

Government has an urgent opportunity to act so Canadian innovations can reach Canadian patients.

opinion | BY ELLIOT FUNG | September 16, 2026

Canada has invested in science. Now it must capture the economic benefits

The challenge now is to turn our strengths into globally competitive companies that retain more intellectual property, jobs, and economic value in Canada.

Mélanie Joly

Biotech sovereignty: Canada’s next strategic imperative

The country excels at generating research and patents, but too often falls short in commercialization, scale-up, and retaining ownership of intellectual property.

opinion | BY MAURA CAMPBELL | September 16, 2026

Canadian health data is a valuable national resource

This data should be treated as a strategic public resource, securely governed in Canada, and used first and foremost for the benefit of Canadians.

opinion | BY FRANK BAYLIS | September 16, 2026

Biotechnology: the brain gain arrives at an empty treasury

Recruiting talent is only the first step, and the pathway is broken at the grant level as funding fails to keep up with recruitment.

opinion | BY ADAM DAMRY | September 16, 2026

Canada’s biotechnology ambitions need more than capital

Maximizing the opportunity will depend on ensuring employers can access the skilled workforce needed to commercialize, scale, and strengthen Canadian capacity.

opinion | BY ROB HENDERSON | September 16, 2026